CTA
SLXP

Chesley Taft & Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Chesley Taft & Associates’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,700
Closed -$734K – 261
2014
Q3 		$734K Sell
4,700
-44,025
-90% -$6.88M 0.08% 157
2014
Q2 		$6.01M Buy
48,725
+16,300
+50% +$2.01M 0.62% 58
2014
Q1 		$3.36M Buy
+32,425
New +$3.36M 0.36% 81